Dimensional Fund Advisors LP Boosts Position in Aveanna Healthcare Holdings Inc. $AVAH

Key Points

• Dimensional Fund Advisors increased its Aveanna Healthcare position by 49.5% in the first quarter, adding 441,707 shares to hold 1.33 million shares worth approximately $8.6 million. Institutional investors collectively own 87.96% of the company.
• Aveanna reported quarterly EPS of $0.18, beating estimates of $0.13, while revenue rose 15.9% year over year to $647.9 million. The stock opened at $9.49, compared with a 52-week range of $5.73 to $10.32.
• Insiders sold more than 31.3 million shares worth approximately $215.6 million during the quarter, including two major shareholders’ sales of 7 million shares each. Analysts remain generally positive, with a consensus “Moderate Buy” rating and a $10.78 price target.

Dimensional Fund Advisors LP raised its position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 49.5% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,334,374 shares of the company's stock after acquiring an additional 441,707 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.61% of Aveanna Healthcare worth $8,593,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company's stock worth $27,000 after buying an additional 2,400 shares during the last quarter. Quantbot Technologies LP bought a new position in Aveanna Healthcare in the second quarter worth approximately $43,000. Summit Securities Group LLC purchased a new position in shares of Aveanna Healthcare during the 1st quarter worth $53,000. Oxford Asset Management LLP purchased a new position in shares of Aveanna Healthcare during the 2nd quarter worth $64,000. Finally, Bayesian Capital Management LP bought a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $85,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Price Performance

NASDAQ:AVAH opened at $9.49 on Monday. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. The business's 50-day simple moving average is $8.62 and its two-hundred day simple moving average is $7.71. The stock has a market cap of $2.07 billion, a PE ratio of 8.04, a P/E/G ratio of 0.94 and a beta of 1.90. Aveanna Healthcare Holdings Inc. has a 52 week low of $5.73 and a 52 week high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The business had revenue of $647.91 million for the quarter, compared to the consensus estimate of $613.22 million. The firm's revenue was up 15.9% compared to the same quarter last year. As a group, analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, major shareholder Paul R. Vigano sold 7,000,000 shares of Aveanna Healthcare stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total value of $43,680,000.00. Following the sale, the insider directly owned 252,899 shares of the company's stock, valued at approximately $1,578,089.76. The trade was a 96.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of the business's stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total value of $43,680,000.00. Following the completion of the sale, the insider owned 252,899 shares in the company, valued at $1,578,089.76. This represents a 96.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 31,305,664 shares of company stock valued at $215,555,910. 5.30% of the stock is owned by company insiders.

Analyst Ratings Changes

AVAH has been the subject of several analyst reports. Stephens upgraded Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. Barclays lifted their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the company an "overweight" rating in a research report on Thursday, July 9th. Royal Bank Of Canada upgraded Aveanna Healthcare from a "sector perform" rating to an "outperform" rating and set a $10.00 price target for the company in a research report on Wednesday, June 3rd. Truist Financial raised their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the stock a "hold" rating in a research note on Tuesday, July 14th. Finally, Weiss Ratings reiterated a "hold (c+)" rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $10.78.

Aveanna Healthcare Profile

Aveanna Healthcare, Inc NASDAQ: AVAH is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source